Navigation Links
Skinvisible's DermSafe(R) Hand Sanitizer Kills Swine Flu Virus
Date:4/28/2009

- Prevention Available to Combat Spread of Viruses

LAS VEGAS, April 28 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI), a research and development company of patented skincare and medical dermatology products, has developed a hand sanitizing lotion that has proven effective in killing the H1N1 swine flu virus found in pigs. Retroscreen Virology of London England conducted the studies with Skinvisible's Hand Sanitizer Lotion; DermSafe. The product demonstrated it had a greater than 99.99 % inactivation/kill on H1N1 influenza A, a virus similar to the human swine flu virus.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO)

The World Health Organization (WHO) yesterday raised the pandemic threat to a phase 4 - "sustained human to human transmission". The Center for Disease Control states that the virus spreads the same way the regular flu does; "Flu viruses are spread mainly from person to person through coughing or sneezing of people with influenza. Sometimes people may become infected by touching something with flu viruses on it and then touching their mouth or nose."

When the lotion is applied to the hands, DermSafe is proven to not only kill bacteria and viruses immediately but also to stay bound to the skin for 4 hours or more; continuing to kill germs - even after hand washing. The product does not contain alcohol and therefore is non-drying and does not present some of the dermatitis issues that alcohol-based products do.

"Skinvisible has a series of studies demonstrating that our DermSafe hand sanitizer kills a host of viruses and bacteria, including several influenza viruses such as H1N1 ('swine flu'), H3N2 and H5N1 ('avian bird flu virus')," said Mr. Terry Howlett, President and CEO of Skinvisible. "We are confident that DermSafe can offer protection for people concerned about spreading germs from person to person and we will continue to undertake more studies on these and other viruses."

The active ingredient in DermSafe is chlorhexidine, which has been used in hospitals worldwide for over fifty years as a pre-surgical hand scrub. DermSafe is available for licensing both commercially in healthcare and food services as well as for personal use (retail) worldwide. DermSafe has been approved for distribution by Health Canada and the company is implementing a plan to seek FDA approval in the US and worldwide.

About Invisicare

Invisicare is Skinvisible's patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. It is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time resisting both wash off and perspiration. Invisicare can control the release of actives, reduce irritation and can eliminate some costly manufacturing processes. It is non-occlusive and allows for normal skin respiration while protecting against environmental irritants. www.invisicare.com

About Skinvisible Pharmaceuticals, Inc

Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. Skinvisible's value also lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare. www.skinvisible.com

Forward-Looking Statements: This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10K for the quarter ending December 31, 2008).

    Corporate Contact:
    Doreen McMorran
    Skinvisible Pharmaceuticals, Inc.
    Phone: 702-433-7154
    Email: info@skinvisible.com


'/>"/>
SOURCE Skinvisible, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SkinWear(TM) Hand Cleaner & Sanitizer Kills Germs That May Cause Swine Flu, Protects Against Germs for Up to Eight Hours
2. ReStockIt.com Greatly Cutting Prices on Hand Sanitizers, Masks to Help Combat Swine Flu Epidemic
3. It Pays to Use Prevention This Cold & Flu Season With Help From NOZIN(R) Nasal Sanitizer(R)
4. Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work
5. Palliative care skills training needed for health-care staff in sub-Saharan Africa
6. Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills
7. New Coaching Program Helps Charge Nurses Develop Leadership Skills: B. E. Smith's Coaches Develop High Performers Who Improve Hospital Finances
8. Active Ingredient in Marijuana Kills Brain Cancer Cells
9. TV Watching Doesnt Fast-Track Babys Skills
10. Paving the Way for Peace in the Middle East with Mind-Body Skills
11. Young People Want Happily Ever After, but Lack Skills to Make Marriage Work
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... on tooth replacement options at his office, Antoine Dental Center. Currently, patients can ... $18,499. Some restrictions may apply, but patients can learn more about these offers ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... In the ... to be a top priority because it’s not if you will be attacked, but ... especially when it comes to digital health care. , Improvements in auditing and monitoring ...
(Date:2/24/2017)... ... 24, 2017 , ... The narrative in “ Signal 8: An Australian Paramedic’s ... of his paramedic experiences. Schanssema describes the tragedies he saw, as well as his ... them. , Schanssema, initially unsure of the career path he wanted to take, found ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Wireless Health Market is poised to ... to reach approximately $330.5 billion by 2025. This industry ... segments on global as well as regional levels presented in the ...
(Date:2/24/2017)... Research and Markets has announced the addition of ... to 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow ... approximately $2.9 billion by 2025. This industry report analyzes ... as well as regional levels presented in the research scope. The study ...
(Date:2/24/2017)... Feb 24, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis and ... Dry eye market. The research answers the following questions: ... and their clinical attributes? How are they positioned in the Global Dry ...
Breaking Medicine Technology: